Randomized, double-blind, double-dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety

被引：0
|
作者：
Olanow, C. W.
Antonini, A.
Kieburtz, K.
Fernandez, H. H.
Espay, A. J.
Standaert, D. G.
Vanagunas, A. D.
Widnell, K. L.
Freeman, S.
Robieson, W. Z.
Pritchett, Y.
Chatamra, K.
Benesh, J.
Lenz, R. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
411
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [1] Randomized, Double-Blind, Double-Dummy Study of Continuous Infusion of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy and Safety
    Olanow, C. Warren
    Antonini, Angelo
    Kieburtz, Karl
    Fernandez, Hubert
    Espay, Alberto
    Standaert, David
    Vanagunas, Arvydas
    Widnell, Katherine
    Freeman, Stefanie
    Robieson, Weining
    Pritchett, Yili
    Chatamra, Krai
    Benesh, Janet
    Lenz, Robert
    NEUROLOGY, 2012, 79 (11) : E87 - E87
  • [2] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy and Safety
    Olanow, C. W.
    Antonini, A.
    Kieburtz, K.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Vanagunas, A.
    Widnell, K. L.
    Freeman, S.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    Lenz, R. A.
    ANNALS OF NEUROLOGY, 2012, 72 : S102 - S102
  • [3] Randomized, double-blind, double-dummy study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy analyses by subgroups
    Antonini, A.
    Chatamra, K.
    Robieson, W. Z.
    Pritchett, Y.
    Widnell, K. L.
    Benesh, J.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 291 - 291
  • [4] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy Analyses by Subgroups
    Antonini, Angelo
    Chatamra, Krai
    Robieson, Weining
    Pritchett, Yili
    Widnell, Katherine
    Benesh, Janet
    Lenz, Robert
    NEUROLOGY, 2013, 80
  • [5] Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
    Olanow, C. Warren
    Kieburtz, Karl
    Odin, Per
    Espay, Alberto J.
    Standaert, David G.
    Fernandez, Hubert H.
    Vanagunas, Arvydas
    Othman, Ahmed A.
    Widnell, Katherine L.
    Robieson, Weining Z.
    Pritchett, Yili
    Chatamra, Krai
    Benesh, Janet
    Lenz, Robert A.
    Antonini, Angelo
    LANCET NEUROLOGY, 2014, 13 (02): : 141 - 149
  • [6] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Functional and Quality-of-Life Outcomes
    Kieburtz, K.
    Antonini, A.
    Olanow, C. W.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Hass, S.
    Widnell, K. L.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    ANNALS OF NEUROLOGY, 2012, 72 : S99 - S99
  • [7] Randomized, phase 3, double-blind, double-dummy study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Functional and quality-of-life outcomes
    Kieburtz, K.
    Antonini, A.
    Olanow, C. W.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Hass, S.
    Widnell, K. L.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    MOVEMENT DISORDERS, 2012, 27 : S124 - S124
  • [8] Design of a randomized, double-blind, double-dummy, placebo-controlled study of levodopa-carbidopa intestinal gel in patients currently receiving optimized treatment for advanced Parkinson's disease
    Olanow, C. W.
    Chatamra, K.
    Benesh, J.
    Pritchett, Y. L.
    Lenz, R. A.
    MOVEMENT DISORDERS, 2011, 26 : S137 - S137
  • [9] for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
    Olen, C. W.
    Kieburtz, K.
    Odin, P.
    LANCET NEUROLOGY, 2014, 13 (03): : 240 - 240
  • [10] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05): : 465 - 476
12345